These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6562000)

  • 21. [The influence of cortisone in treatment of pseudomonas aeruginosa keratitis in rabbit eyes].
    Behrens-Baumann W; Paul HH; Ansorg R
    Klin Monbl Augenheilkd; 1981 Mar; 178(3):200-2. PubMed ID: 7230716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a synthetic metalloproteinase inhibitor on corneal ulceration in alkali burns and pseudomonas keratitis.
    Burns FR; Gray RD; Wells JT; Paterson CA
    Matrix Suppl; 1992; 1():317-8. PubMed ID: 1480049
    [No Abstract]   [Full Text] [Related]  

  • 23. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of tobramycin on gentamicin-resistant strains in Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1974 Apr; 77(4):583-8. PubMed ID: 4206621
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of pseudomonas infection of the rabbit cornea. Comparative study.
    Furgiuele FP
    Am J Ophthalmol; 1968 Aug; 66(2):276-9. PubMed ID: 4298724
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rat model of bacterial keratitis. Effect of antibiotics and corticosteroid.
    Badenoch PR; Hay GJ; McDonald PJ; Coster DJ
    Arch Ophthalmol; 1985 May; 103(5):718-22. PubMed ID: 3843063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model.
    Sensoy D; Cevher E; Sarici A; Yilmaz M; Ozdamar A; Bergişadi N
    Eur J Pharm Biopharm; 2009 Aug; 72(3):487-95. PubMed ID: 19223014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental pseudomonas keratitis. Treatment with and evaluation of carbenicillin and gentamicin in combination.
    Bohigian G; Okumoto M; Valenton M
    Arch Ophthalmol; 1971 Oct; 86(4):432-7. PubMed ID: 4329268
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental Pseudomonas keratitis.
    Hyndiuk RA
    Trans Am Ophthalmol Soc; 1981; 79():541-624. PubMed ID: 6805124
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of minimal antibiotic treatment on bacterial keratitis.
    Hodges EJ; Friedlaender MH; Lee A; Okumoto M
    Cornea; 1989 Sep; 8(3):188-90. PubMed ID: 2501067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of proteases in Pseudomonas otitis media in chinchillas.
    Cotter CS; Avidano MA; Stringer SP; Schultz GS
    Otolaryngol Head Neck Surg; 1996 Oct; 115(4):342-51. PubMed ID: 8861889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Willcox MD
    Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
    Hobden JA; O'Callaghan RJ; Hill JM; Hagenah M; Insler MS; Reidy JJ
    Curr Eye Res; 1992 Mar; 11(3):259-65. PubMed ID: 1587148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
    Davis SD; Sarff LD; Hyndiuk RA
    Can J Ophthalmol; 1980 Jan; 15(1):28-9. PubMed ID: 6769572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of tobramycin on Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1973 Oct; 76(4):555-60. PubMed ID: 4200625
    [No Abstract]   [Full Text] [Related]  

  • 39. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
    Rootman DS; Hobden JA; Jantzen JA; Gonzalez JR; O'Callaghan RJ; Hill JM
    Arch Ophthalmol; 1988 Feb; 106(2):262-5. PubMed ID: 3124801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.